An OspA Serotyping System for Borrelia Burgdorferi Based on Reactivity with Monoclonal Antibodies and OspA Sequence Analysis

Overview

Journal J Clin Microbiol

Specialty Microbiology

Date 1993 Feb 1

PMID 8432821

Citations 138

Authors

B Wilske

V Preac-Mursic

U B Gobel

B Graf

S Jauris

E Soutschek

E Schwab

G Zumstein

Affiliations

Soon will be listed here.

Abstract

A total of 136 Borrelia burgdorferi sensu latu strains from various biological sources (ticks, human skin, and cerebrospinal fluid) and geographical sources (Europe and North America) were investigated by Western blot (immunoblot) with eight monoclonal antibodies against different epitopes of the outer surface protein A (OspA). On the basis of the differential reactivities of these monoclonal antibodies, seven OspA serotypes were defined. As determined by 16S rRNA sequence analysis, these serotypes correlated well with recently delineated genospecies: serotype 1 corresponds to B. burgdorferi sensu strictu, serotype 2 corresponds to group VS461, and serotypes 3 to 7 correspond to Borrelia garinii sp. nov. (G. Baranton, D. Postic, I. Saint Girons, P. Boerlin, J.-C. Piffaretti, M. Assous, and P. A. D. Grimont, Int. J. Syst. Bacteriol. 42:378-383, 1992). Antigenic differences were confirmed by partial sequence analysis of OspA of representatives of each serotype. Comparative sequence analysis suggested that serotype 5 OspA resulted from genetic recombination of serotype 4 and 6 ospA genes. Serotype 2 (group VS461) was most prevalent among European skin isolates (49 of 62 isolates). Among all B. garinii strains included in this study, serotype 6 was most frequently found in ticks and only rarely in human skin and cerebrospinal fluid, whereas serotypes 4 and 5 were isolated from patients but never from ticks. Our data suggest different pathogenic potentials and organotropisms of distinct OspA serotypes and raise the question of true antigenic variation among B. garinii strains.

Citing Articles

Complex exchanges among plasmids and clonal expansion of lineages shape the population structure and virulence of .

Laing R, Foster M, Hassani M, Kotzen B, Huang W, Shea T bioRxiv. 2025; .

PMID: 39974970 PMC: 11838331. DOI: 10.1101/2025.01.29.635312.

CspZ variant-specific interaction with factor H incorporates a metal site to support Lyme borreliae complement evasion.

Brangulis K, Surth V, Marcinkiewicz A, Akopjana I, Kazaks A, Bogans J J Biol Chem. 2024; 301(1):108083.

PMID: 39675703 PMC: 11773018. DOI: 10.1016/j.jbc.2024.108083.

A single immunization of -infected mice with Vanguard crLyme elicits robust antibody responses to diverse strains and variants of outer surface protein C.

Chambers G, Chambers K, Marconi R Infect Immun. 2024; 92(11):e0039624.

PMID: 39436053 PMC: 11556006. DOI: 10.1128/iai.00396-24.

Development of a sequence-based OspA typing method for .

Lee J, Li Z, Nunez L, Katzel D, Perrin Jr B, Raghuraman V Microb Genom. 2024; 10(5).

PMID: 38787376 PMC: 11165634. DOI: 10.1099/mgen.0.001252.

Single-domain antibodies reveal unique borrelicidal epitopes on the Lyme disease vaccine antigen, outer surface protein A (OspA).

Vance D, Basir S, Piazza C, Willsey G, Haque H, Tremblay J Infect Immun. 2024; 92(4):e0008424.

PMID: 38470113 PMC: 11003225. DOI: 10.1128/iai.00084-24.

References

Fikrig E, Barthold S, Kantor F, Flavell R . Protection of mice against the Lyme disease agent by immunizing with recombinant OspA. Science. 1990; 250(4980):553-6. DOI: 10.1126/science.2237407. View

Brown R, Lane R . Lyme disease in California: a novel enzootic transmission cycle of Borrelia burgdorferi. Science. 1992; 256(5062):1439-42. DOI: 10.1126/science.1604318. View

Barbour A, Tessier S, Hayes S . Variation in a major surface protein of Lyme disease spirochetes. Infect Immun. 1984; 45(1):94-100. PMC: 263275. DOI: 10.1128/iai.45.1.94-100.1984. View

Weber K, SCHIERZ G, Wilske B, Preac-Mursic V . [Clinical aspects and etiology of acrodermatitis chronica atrophicans]. Hautarzt. 1984; 35(11):571-7. View

Schmid G . The global distribution of Lyme disease. Rev Infect Dis. 1985; 7(1):41-50. DOI: 10.1093/clinids/7.1.41. View

Wilske B, Preac-Mursic V, SCHIERZ G . Antigenic heterogeneity of European Borrelia burgdorferi strains isolated from patients and ticks. Lancet. 1985; 1(8437):1099. DOI: 10.1016/s0140-6736(85)92396-7. View

Barbour A, Heiland R, Howe T . Heterogeneity of major proteins in Lyme disease borreliae: a molecular analysis of North American and European isolates. J Infect Dis. 1985; 152(3):478-84. DOI: 10.1093/infdis/152.3.478. View

Asbrink E, Hovmark A, Olsson I . Clinical manifestations of acrodermatitis chronica atrophicans in 50 Swedish patients. Zentralbl Bakteriol Mikrobiol Hyg A. 1986; 263(1-2):253-61. DOI: 10.1016/s0176-6724(86)80128-6. View

Hinnebusch J, Barbour A . Linear- and circular-plasmid copy numbers in Borrelia burgdorferi. J Bacteriol. 1992; 174(16):5251-7. PMC: 206359. DOI: 10.1128/jb.174.16.5251-5257.1992. View

10.

Baranton G, Postic D, Saint Girons I, Boerlin P, Piffaretti J, Assous M . Delineation of Borrelia burgdorferi sensu stricto, Borrelia garinii sp. nov., and group VS461 associated with Lyme borreliosis. Int J Syst Bacteriol. 1992; 42(3):378-83. DOI: 10.1099/00207713-42-3-378. View

11.

Sadziene A, Rosa P, Thompson P, Hogan D, Barbour A . Antibody-resistant mutants of Borrelia burgdorferi: in vitro selection and characterization. J Exp Med. 1992; 176(3):799-809. PMC: 2119346. DOI: 10.1084/jem.176.3.799. View

12.

Peter O, Bretz A . Polymorphism of outer surface proteins of Borrelia burgdorferi as a tool for classification. Zentralbl Bakteriol. 1992; 277(1):28-33. DOI: 10.1016/s0934-8840(11)80867-4. View

13.

Zumstein G, Fuchs R, Hofmann A, Preac-Mursic V, Soutschek E, Wilske B . Genetic polymorphism of the gene encoding the outer surface protein A (OspA) of Borrelia burgdorferi. Med Microbiol Immunol. 1992; 181(2):57-70. DOI: 10.1007/BF00189424. View

14.

Wilske B, Luft B, Schubach W, Zumstein G, Jauris S, Preac-Mursic V . Molecular analysis of the outer surface protein A (OspA) of Borrelia burgdorferi for conserved and variable antibody binding domains. Med Microbiol Immunol. 1992; 181(4):191-207. DOI: 10.1007/BF00215765. View

15.

Barbour A, Schrumpf M . Polymorphisms of major surface proteins of Borrelia burgdorferi. Zentralbl Bakteriol Mikrobiol Hyg A. 1986; 263(1-2):83-91. DOI: 10.1016/s0176-6724(86)80107-9. View

16.

Wilske B, Preac-Mursic V, SCHIERZ G, Busch K . Immunochemical and immunological analysis of European Borrelia burgdorferi strains. Zentralbl Bakteriol Mikrobiol Hyg A. 1986; 263(1-2):92-102. DOI: 10.1016/s0176-6724(86)80108-0. View

17.

Barbour A, Garon C . Linear plasmids of the bacterium Borrelia burgdorferi have covalently closed ends. Science. 1987; 237(4813):409-11. DOI: 10.1126/science.3603026. View

18.

Mursic V, Wilske B, SCHIERZ G, Holmburger M, Suss E . In vitro and in vivo susceptibility of Borrelia burgdorferi. Eur J Clin Microbiol. 1987; 6(4):424-6. DOI: 10.1007/BF02013102. View

19.

Temin H . Mechanisms of cell killing/cytopathic effects by nonhuman retroviruses. Rev Infect Dis. 1988; 10(2):399-405. DOI: 10.1093/clinids/10.2.399. View

20.

Wilske B, Preac-Mursic V, SCHIERZ G, Gueye W, Herzer P, Weber K . [Immunochemical analysis of the immune response in late manifestations of Lyme borreliosis]. Zentralbl Bakteriol Mikrobiol Hyg A. 1988; 267(4):549-58. View